Strategic Collaborations Synaffix BV has established numerous strategic collaborations with leading biopharma companies, translating into significant revenue potential through technology out-licensing deals and partnerships in ADC development.

Innovative Technology The proprietary ADC technology platform of Synaffix BV offers a competitive edge in generating best-in-class ADCs, presenting an opportunity to attract new partners and expand market reach with innovative solutions.

Industry Recognition Recent integration with Bighatbio and planned launch of new ADC technologies at renowned conferences like the World ADC conference in San Diego increases visibility and credibility, opening doors to engage with a wider audience of potential clients.

Rapid Development Pipeline With over 20 ADCs currently in development and three novel ADCs in the pipeline, Synaffix BV demonstrates a robust portfolio and capability for swiftly meeting the evolving needs of the market, potentially attracting investors and collaborators looking for growth opportunities.

Acquisition Impact The acquisition by Lonza not only validates the strength of Synaffix's technology but also offers access to a broader client base and resources, creating a favorable environment for accelerated business expansion and revenue growth.